Clinical Trial Update: A Study on Molecular Genetics of Drug Responsiveness in Essential Hypertension [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing molecular genetics of drug responsiveness in essential hypertension has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Snippet

Sponsor: Helsinki University Central Hospital | Conditions: Hypertension, Pharmacogenetics | Phase 4 | Status: COMPLETED